trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Hepatitis B vaccines for newborns are safe and cost-effective

the verdict
SUPPORTED
the evidence backs this
Recorded sources
5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that hepatitis B vaccines for newborns are safe and cost-effective?

Yes. Evidence from global health data, systematic reviews, and economic models consistently supports the safety, efficacy, and cost-effectiveness of hepatitis B vaccination protocols for newborns and infants.

Verdict: SUPPORTED · 5 sources for, 0 against · Last checked

The analysis

The retrieved literature thoroughly supports the claim that hepatitis B vaccines are safe and cost-effective, particularly in the context of newborn and childhood immunization programs. Papers 1, 2, 4, 5, and 7 provide direct or supportive evidence regarding safety, efficacy, and cost-effectiveness (including modeling and review data). No papers refute the core claim.

Evidence for · 5
Vertical transmission of hepatitis B virus: challenges and solutions
2014
Demonstrates that at-birth hepatitis B vaccination for newborns of infected mothers is effective in preventing vertical transmission.
Get citation
Gentile, I. & Borgia, G. (2014). Vertical transmission of hepatitis B virus: challenges and solutions. doi.org. https://doi.org/10.2147/IJWH.S51138

See more details
More for · 4
Hepatitis B Vaccination: A Historical Overview with a Focus on the Italian Achievements
2022
Shows that global infant and childhood hepatitis B vaccination programs have an excellent profile of safety, immunogenicity, and effectiveness.
Get citation
Romanò, L. & Zanetti, A. (2022). Hepatitis B Vaccination: A Historical Overview with a Focus on the Italian Achievements. doi.org. https://doi.org/10.3390/v14071515

Mathematical Model of Hepatitis B Disease with Optimal Control and Cost-Effectiveness Analysis
2023
Indicates through mathematical modeling that enhanced newborn vaccination combined with prevention strategies is an effective and cost-saving approach.
Get citation
Belay, M. A., Abonyo, O. J., & Theuri, D. (2023). Mathematical Model of Hepatitis B Disease with Optimal Control and Cost-Effectiveness Analysis. doi.org. https://doi.org/10.1155/2023/5215494

Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses
2023
Confirms through an umbrella review of meta-analyses that universal and targeted hepatitis B vaccination strategies are effective and safe.
Get citation
Qiu, J., Zhang, S., Feng, Y., Su, X., Cai, J., Chen, S., Liu, J., Huang, S., Huang, H., Zhu, S., Wen, H., Li, J., Yan, H., Diao, Z., Liang, X., & Zeng, F. (2023). Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses. doi.org. https://doi.org/10.1080/14760584.2023.2289566

Cost-effectiveness analysis of hepatitis B vaccine booster in children born to HBsAg-positive mothers in rural China.
2019
Finds that specific booster strategies for high-risk children born to HBsAg-positive mothers are cost-effective.
Get citation
Wang, Y., Shi, J., Wang, L., Yan, Y., Yao, H., Dai, M., Chen, T., & Qu, C. (2019). Cost-effectiveness analysis of hepatitis B vaccine booster in children born to HBsAg-positive mothers in rural China.. doi.org. https://doi.org/10.1016/j.ijid.2018.08.024

Receipt History
first checked06 Aug 2026
judged → SUPPORTED · 8806 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work